Bioactive compounds in the nutrition of peri- and postmenopausal women within the concept of 4P-medicine

Abstract

An updated consensus statement from the European Menopause and Andropause Society noted that a woman’s quality of life may decline during peri- and post-menopause as a result of various menopausal symptoms and age-related comorbidities.

The purpose of the work was to assess the possibility of using bioactive compounds in peri- and postmenopausal women to prevent the development of menopausal complications and chronic diseases associated with aging.

Material and methods. Literature search was carried out using PubMed, Google Scholar, ResearchGate, RSCI databases mainly over the past 10 years, with the exception of works of fundamental importance, according to the keywords “perimenopause”, “postmenopause”, “Affron® saffron extract”, “special extract ERr 731”.

Results. The use of diet, dietary supplements including those containing extracts of saffron (Affron®) and Siberian rhubarb (ERr 731) and their biologically active substances, has a versatile effect on the correction of menopausal disorders due to the impact on various pathogenetic pathways of their development and can be used in women in this period as a phytonutrient support.

Conclusion. The combined use of saffron and Siberian rhubarb extracts is promising from the point of view of correcting the female state during peri- and postmenopause, taking into account the pathogenetic moments of the development of menopausal complications and chronic diseases associated with aging.

Keywords:perimenopause; postmenopause; Affron® saffron extract; special Siberian rhubarb extract ERr 731

Funding. The study was not sponsored.

Conflict of interest. The authors declare no conflict of interest.

Contribution. The concept and design of the study – Vorontsova A.V.; collection of material, writing and editing the text, approval of the final version of the article, responsibility for the integrity of all parts of the article – all authors.

For citation: Vorontsova A.V., Pogozheva A.V. Bioactive compounds in the nutrition of peri- and postmenopausal women within the concept of 4P-medicine. Voprosy pitaniia [Problems of Nutrition]. 2023; 92 (2): 6–17. DOI: https://doi.org/10.33029/0042-8833-2023-92-2-6-17 (in Russian)

References

1. Lambrinoudaki I., Armeni E., Goulis D., Bretz S., Ceausu I., Durmusoglu F., et al. Menopause, wellbeing and health: A care pathway from the European Menopause and Andropause Society. Maturitas. 2022; 163: 1–14. DOI: https://doi.org/10.1016/j.maturitas.2022.04.008

2. Paltsev M.A., Belushkina N.N., Chaban E.A. 4P-Medicine as a new model of healthcare in the Russian Federation. Healthcare management: news, views, education. 2015; (2): 48–54. (in Russian)

3. Osmanov E.M., Manyakov R.R., Osmanov R.E., Zhabina U.V., Konyaev D.А., Agafonova Y.V., et al. 4 “P” medicine as a basis of new system of public health. Vestnik Tambovskogo universiteta [Tambov University Reports]. Series: Natural and Technical Sciences. 2017; 22 (6): 1680–5. DOI: https://doi.org/10.20310/1810-0198-2017-22-6-1680-1685 (in Russian)

4. Maksimenko L.V. Epigenetics as an evidence base of the impact of lifestyle on health and disease. Profilakticheskaya meditsina [Preventive Medicine]. 2019; 22 (2): 115‑20. DOI: https://doi.org/10.17116/profmed201922021115 (in Russian)

5. Nappi R.E., Chedraui P., Lambrinoudaki I., Simoncini T. Menopause: a cardiometabolic transition. Lancet Diabetes Endocrinol. 2022; 10 (6): 442‑56. DOI: https://doi.org/10.1016/S2213-8587(22)00076-6

6. Kase N.G., Friedman E.G., Brodman M. The mid-life transition and the risk of cardiovascular disease and cancer Part II: strategies to maximize quality of life and limit dysfunction and disease. Am J Obstet Gynecol. 2020; 223 (6): 834‑47. DOI: https://doi.org/10.1016/j.ajog.2020.06.008

7. Clinical recommendations “Menopause and menopausal condition in women”. ID 117; 2021 https://cr.minzdrav.gov.ru/recomend/117_2 (in Russian)

8. Pizzorno J.E., Murray M.T., Bay H.Jr. Guide to Natural Medicine / translated from English. Edited by A.V. Pogozheva. Moscow : Litterra, 2022: 1032 p. DOI: https://doi.org/10.33029/4235-0369-7-RNM-2022-1-1032; ISBN 978-0-7020-5514-0 (Eng.)

9. Tutelyan V.A., Pogozheva A.V., Vysotsky V.G. Clinical and hygienic aspects of soy application. Moscow: Publishing House “New Millennium”, 2005: 257 p. (in Russian)

10. Martinchik A.N., Zubtsov V.V. Phytoestrogenic properties of flax seed lignans. Voprosy pitaniya [Problems of Nutrition]. 2012; 86 (6): 61‑6. (in Russian)

11. Koval M.V., Udachina A.A. Role of vitamin D in formationof climacteric syndrome. Permskiĭ meditsinskiĭ zhurnal [Perm Medical Journal]. 2022; 39 (6): 5‑10. DOI: https://doi.org/10.17816/pmj3965-10 (in Russian)

12. Kodentsova V.M., Risnik D.V. Vitamin D – an alimentary factor in the prevention of diseases caused by its defi ciency. Meditsinskiy sovet [Medical Council]. 2022; 16 (6): 70‑80. DOI: https://doi.org/10.21518/2079-701X-2022-16-2 (in Russian)

13. Get into prime time. Menopausal syndrome and phytonutrient support: Newsletter / O.A. Bykova; edited by Radzinsky V.E. Moscow: Media bureau “StatusPraesens”, 2022: 16 p. ISBN 978-5-907218-38-3 (in Russian)

14. El Midaoui A., Ghzaiel I., Vervandier-Fasseur D., Ksila M., Zarrouk A., Nury T., et al. Saffron (Crocus sativus L.): A Source of Nutrients for Health and for the Treatment of Neuropsychiatric and Age-Related Diseases. Nutrients. 2022; 14 (3): 597. DOI: https://doi.org/10.3390/nu14030597

15. Siddiqui S.A., Ali Redha A., Snoeck E.R., Singh S., Simal-Gandara J., Ibrahim S.A., et al. Anti-Depressant Properties of Crocin Molecules in Saffron. Molecules. 2022; 27 (7): 2076. DOI: https://doi.org/10.3390/molecules27072076

16. Aucante P. Le safran-chroniques du potager / Actes sud Ed., 2000.

17. Hosseini A., Razavi B.M., Hosseinzadeh H. Pharmacokinetic Properties of Saffron and its Active Components. Eur J Drug Metab Pharmacokinet. 2018; 43: 383–90. DOI: https://doi.org/10.1007/s13318-017-0449-3

18. Poursamimi J., Shariati-Sarabi Z., Tavakkol-Afshari J., Mohajeri S.A., Ghoryani M., Mohammadi M. Immunoregulatory effects of Krocina™, a herbal medicine made of crocin, on osteoarthritis patients: A successful clinical trial in Iran. Iran J Allergy Asthma Immunol. 2020; 19: 253–63.

19. Puglia C., Santonocito D., Musumeci T., Cardile V., Graziano A.C.E., Salerno L., et al. Nanotechnological Approach to Increase the Antioxidant and Cytotoxic Efficacy of Crocin and Crocetin. Planta Med. 2019; 85: 258–65. DOI: https://doi.org/10.1055/a-0732-5757

20. EFSA Panel on Nutrition, Novel foods and Food allergens (NDA), Turck D., Castenmiller J., De Henauw S., Hirsch-Ernst K.I., Kearney J., Knutsen H.K., et al. Affron® and increase in positive mood: evaluation of a health claim pursuant to Article 13 (5) of Regulation (EC) No 1924/2006. EFSA J. 2021; 19 (7): e06660. DOI: https://doi.org/10.2903/j.efsa.2021.6669

21. Taavoni S., Ekbatani N.N., Haghani H. Effect of Tribulus terrestris, ginger, saffron, and Cinnamomum on menopausal symptoms: A randomised, placebo-controlled clinical trial. Prz. Menopauzalny. 2017; 16: 19–22. DOI: https://doi.org/10.5114/pm.2017.67366

22. Kashani L., Esalatmanesh S., Eftekhari F., Salimi S., Foroughifar T., Etesam F., et al. Efficacy of Crocus sativus (saffron) in treatment of major depressive disorder associated with post-menopausal hot flashes: a double-blind, randomized, placebo-controlled trial. Arch Gynecol Obstet. 2018; 297 (3): 717–24. DOI: https://doi.org/10.1007/s00404-018-4655-2; PMID: 29332222

23. Lopresti A.L., Smith S.J. The Effects of a Saffron Extract (Affron®) on Menopausal Symptoms in Women during Perimenopause: A Randomised, Double-Blind, Placebo-Controlled Study. J Menopausal Med. 2021; 27 (2): 66–78. DOI: https://doi.org/10.6118/jmm.21002

24. Srivastava R., Ahmed H., Dixit R.K., Dharamveer, Saraf S.A. Crocus sativus L.: A comprehensive review. Pharmacogn Rev. 2010; 4 (8): 200–8. DOI: https://doi.org/10.4103/0973-7847.70919

25. Matraszek-Gawron R., Chwil M., Terlecki K., Skoczylas M.M. Current Knowledge of the Antidepressant Activity of Chemical Compounds from Crocus sativus L. Pharmaceuticals. 2023; 16 (1): 58. DOI: https://doi.org/10.3390/ph16010058

26. Cerdá-Bernad D., Costa L., Serra A.T., Bronze M.R., Valero-Cases E., Pérez-Llamas F., et al. Saffron against Neuro-Cognitive Disorders: An Overview of Its Main Bioactive Compounds, Their Metabolic Fate and Potential Mechanisms of Neurological Protection. Nutrients. 2022; 14 (24): 5368. DOI: https://doi.org/10.3390/nu14245368

27. Lu C., Ke L., Li J., Zhao H., Lu T., Mentis A.F.A., et al. Saffron (Crocus sativus L.) and health outcomes: a meta-research review of meta-analyses and an evidence mapping study. Phytomedicine. 2021; 91: 153699. DOI: https://doi.org/10.1016/j.phymed.2021.153699

28. Khoshandam A., Razavi B.M., Hosseinzadeh H. Interaction of saffron and its constituents with Nrf2 signaling pathway: A review. Iran J Basic Med Sci. 2022; 25 (7): 789–98. DOI: https://doi.org/10.22038/IJBMS.2022.61986.13719

29. Omidkhoda S.F., Hosseinzadeh H. Saffron and its active ingredients against human disorders: A literature review on existing clinical evidence. Iran J Basic Med Sci. 2022; 25 (8): 913–33. DOI: https://doi.org/10.22038/IJBMS.2022.63378.13985

30. Boozari M., Hosseinzadeh H. Crocin molecular signaling pathways at a glance: A comprehensive review. Phytother Res. 2022; 36 (10): 3859–84. DOI: https://doi.org/10.1002/ptr.7583

31. Vafaei S., Wu X., Tu J., Nematollahi-Mahani S.N. The Effects of Crocin on Bone and Cartilage Diseases. Front Pharmacol. 2022; 12: 830331. DOI: https://doi.org/10.3389/fphar.2021.830331

32. Rashid M., Brim H., Ashktorab H. Saffron, Its Active Components, and Their Association with DNA and Histone Modification: A Narrative Review of Current Knowledge. Nutrients. 2022; 14 (16): 3317. DOI: https://doi.org/10.3390/nu14163317

33. Mir M.A., Ganai S.A., Mansoor S., Jan S., Mani P., Masoodi K.Z., et al. Isolation, Purification and Characterization of Naturally Derived Crocetin Beta-D-Glucosyl Ester from Crocus Sativus L. Against Breast Cancer and its Binding Chemistry with ER-alpha/HDAC2. Saudi J. Biol. Sci. 2020; 27 (3): 975–84. DOI: https://doi.org/10.1016/j.sjbs.2020.01.018

34. Li S., Shen X.Y., Ouyang T., Qu Y., Luo T., Wang H.Q. Synergistic anticancer effect of combined crocetin and cisplatin on KYSE-150 cells via p53/p21 pathway. Cancer Cell Int. 2017; 17: 98. DOI: https://doi.org/10.1186/s12935-017-0468-9

35. Chahine N., Hanna J., Makhlouf H., Duca L., Martiny L., Chahine R. Protective effect of saffron extract against doxorubicin cardiotoxicity in isolated rabbit heart. Pharm Biol. 2013; 51: 1564–71. DOI: https://doi.org/10.3109/13880209.2013.802812

36. Liudvytska O., Kolodziejczyk-Czepas J. A Review on Rhubarb-Derived Substances as Modulators of Cardiovascular Risk Factors-A Special Emphasis on Anti-Obesity Action. Nutrients. 2022; 14 (10): 2053. DOI: https://doi.org/10.3390/nu14102053

37. Chang J.L., Montalto M.B., Heger P.W., Thiemann E., Rettenberger R., Wacker J. Rheum rhaponticum Extract (ERr 731): Postmarketing Data on Safety Surveillance and Consumer Complaints. Integr Med (Encinitas). 2016; 15 (3): 34–9. PMID: 27547165; PMCID: PMC4982646

38. Wober J., Möller F., Richter T., Unger C., Weigt C., Jandausch A., et al. Activation of estrogen receptor-beta by a special extract of Rheum rhaponticum (ERr 731), its aglycones and structurally related compounds. J Steroid Biochem Mol Biol. 2007; 107 (3-5): 191–201. DOI: https://doi.org/10.1016/j.jsbmb.2007.04.002

39. Wilson M., Konda V., Heidt K., Rathinasabapathy T., Desai A., Komarnytsky S. Rheum rhaponticum Root Extract Improves Vasomotor Menopausal Symptoms and Estrogen-Regulated Targets in Ovariectomized Rat Model. Int J Mol Sci. 2021; 22 (3): 1032. DOI: https://doi.org/10.3390/ijms22031032

40. Dietz B.M., Hajirahimkhan A., Dunlap T.L., Bolton J.L. Botanicals and Their Bioactive Phytochemicals for Women’s Health. Pharmacol Rev. 2016; 68 (4): 1026–073. DOI: https://doi.org/10.1124/pr.115.010843

41. Kaszkin-Bettag M., Beck S., Richardson A., Heger P.W., Beer A.M. Efficacy of the special extract ERr 731 from rhapontic rhubarb for menopausal complaints: a 6-month open observational study. Altern Ther Health Med. 2008; 14 (6): 32–8. PMID: 19043936

42. Kaszkin-Bettag M., Ventskovskiy B.M., Solskyy S., Beck S., Hasper I., Kravchenko A., et al. Confirmation of the efficacy of ERr 731 in perimenopausal women with menopausal symptoms. Altern Ther Health Med. 2009; 15 (1): 24–34. PMID: 19161045.

43. Heger M., Ventskovskiy B.M., Borzenko I., Kneis K.C., Rettenberger R., Kaszkin-Bettag M., et al. Efficacy and safety of a special extract of Rheum rhaponticum (ERr 731) in perimenopausal women with climacteric complaints: a 12-week randomized, double-blind, placebo-controlled trial. Menopause. 2006; 13 (5): 744–59. DOI: https://doi.org/10.1097/01.gme.0000240632.08182.e4. Erratum in: Menopause. 2007; 14 (2): 339. PMID: 16894335.

44. Lee W., Yoon G., Hwang Y.R., Kim Y.K., Kim S.N. Anti-obesity and hypolipidemic effects of Rheum undulatum in high-fat diet-fed C57BL/6 mice through protein tyrosine phosphatase 1B inhibition. BMB Rep. 2012, 45: 141–6.

45. Yang M., Li X., Zeng X., Ou Z., Xue M., Gao D., et al. Rheum palmatum L. attenuates high fat diet-induced hepatosteatosis by activating AMP-activated protein kinase. Am J Chin Med. 2016; 44: 551–64.

46. Liu Y.-F. Treatment with rhubarb improves brachial artery endothelial function in patients with atherosclerosis: A randomized, double-blind, placebo-controlled clinical trial. Am J Chin Med. 2007; 35: 583–95.

47. Jo S.P., Kim J.K., Lim Y.H. Antihyperlipidemic effects of rhapontin and rhapontigenin from rheum undulatum in rats fed a high-cholesterol diet. Planta Med. 2014; 80: 1067–71. DOI: https://doi.org/10.1055/s-0034-1382999

48. Chen J., Ma M., Lu Y., Wang L., Wu C., Duan H. Rhaponticin from rhubarb rhizomes alleviates liver steatosis and improves blood glucose and lipid profiles in KK/Ay diabetic mice. Planta Med. 2009; 75: 472–7. DOI: https://doi.org/10.1055/s-0029-1185304

49. Reimer R.A., McBurney M.I. Dietary fiber modulates intestinal pro-glucagon messenger ribonucleic acid and postprandial secretion of glucagon-like peptide-1 and insulin in rats. Endocrinology. 1996; 137: 3948–56. DOI: https://doi.org/10.1210/endo.137.9.8756571

50. Reimer R.A., Thomson A.B., Rajotte R.V., Basu T.K., Ooraikul B., McBurney M.I. A physiological level of rhubarb fiber increases proglucagon gene expression and modulates intestinal glucose uptake in rats. J Nutr. 1997; 127: 1923–8. DOI: https://doi.org/10.1093/jn/127.10.1923

51. Shojaei Shad F., Haghighi M.J. Study of the effect of the essential oil (extract) of rhubarb stem (shoot) on glycosylated hemoglobin and fasting blood glucose levels in patients with type II diabetes. Biomedicine. 2018; 8: 24. DOI: https://doi.org/10.1051/bmdcn/2018080424

52. Jiang C.S., Liang L.F., Guo Y.W. Natural products possessing protein tyrosine phosphatase 1B (PTP1B) inhibitory activity found in the last decades. Acta Pharmacol Sin. 2012; 33: 1217–45. DOI: https://doi.org/10.1038/aps.2012.90

53. Saidu Y., Muhammad S.A., Abbas A.Y., Onu A., Tsado I.M., Muhammad L. In vitro screening for protein tyrosine phosphatase 1B and dipeptidyl peptidase IV inhibitors from selected Nigerian medicinal plants. J Intercult Ethnopharmacol. 2016; 6: 154–7.

All articles in our journal are distributed under the Creative Commons Attribution 4.0 International License (CC BY 4.0 license)

SCImago Journal & Country Rank
Scopus CiteScore
CHIEF EDITOR
CHIEF EDITOR
Viktor A. Tutelyan
Full Member of the Russian Academy of Sciences, Doctor of Medical Sciences, Professor, Scientific Director of the Federal Research Centre of Nutrition, Biotechnology and Food Safety (Moscow, Russia)

Journals of «GEOTAR-Media»